Annual Report

2015

Cochrane Germany – Annual Report 2015

2/37

Contents

Contents .................................................................................................................. 2

Introduction ............................................................................................................. 3

Funding .................................................................................................................... 5

Projects in 2015 (selection) ....................................................................................... 5

Systematic Reviews at CG in 2015 ............................................................................. 7

Protocols at CG in 2015 ............................................................................................. 9

International Activities & Networking ....................................................................... 9

Further activities .................................................................................................... 10

Implementation of Cochrane rebranding ................................................................ 10

Workshops, Training and Events ............................................................................. 11

Contribution to the “Cochrane Library”: The Cochrane Central Register of Controlled

Trials ...................................................................................................................... 13

Cochrane in Germany ............................................................................................. 15

Cochrane Review Groups based in Germany ........................................................... 18

Branches of Cochrane Germany .............................................................................. 19

Staff in 2015 ........................................................................................................... 22

Publications of the CG staff in 2015 ........................................................................ 24

Presentations of CG staff in 2015 ............................................................................ 30

Imprint:

Cochrane Germany (2016)

Medical Center – University of Freiburg

Berliner Allee 29

79110 Freiburg, Germany

Tel. +49 761 203 6715

Fax +49 761 203 6712

E-Mail: mail@cochrane.de

www.cochrane.de // www.cochrane.org // www.thecochranelibrary.com

funded by:

Cochrane Germany – Annual Report 2015

3/37

Introduction

Cochrane Germany (CG) is the representative of the international Cochrane

Collaboration (CC) in Germany. Furthermore, it is the reference centre for the

German speaking part of Switzerland, for Austria, Liechtenstein, the Czech Republic,

Slovakia and Hungary (for branches s. page 19). The CC is an international not-for-

profit organization whose “vision is a world of improved health where decisions about

health and health care are informed by high-quality, relevant and up-to-date

synthesized research evidence” (www.cochrane.org). To achieve this, more than

37,000 people from over 130 countries work together in preparing, updating and

promoting systematic reviews about health care interventions. To date, over 9,200

Cochrane Reviews are published in the Cochrane Library

(www.cochranelibrary.com). The national centres are tasked to deliver the following

‘core functions’ in their countries:

1. To promote and represent The Cochrane Collaboration.

2. To serve as a source of information about The Cochrane Collaboration. 3. To provide or facilitate training and support for review authors, editors,

handsearchers and other contributors to The Cochrane Collaboration.

4. To support regional editorial bases of Review Groups, Methods Groups and Fields by: assistance to find funding and mediating conflicts, either between Cochrane

entities or between individuals and entities.

5. To contribute to improving the quality of Cochrane reviews by performing,

supporting or promoting methodological research. 6. To promote accessibility to The Cochrane Library to healthcare professionals,

patients and others, e.g. by pursuing national subscriptions and translations

where necessary. 7. To handsearch general healthcare journals in the linguistic area of the Centre and

to submit the search results to the Collaboration’s trial database. *

* Core functions are currently being reviewed and might be adapted in the future.

In addition to the core functions as a centre of the CC, the German centre acts as a

national ‘hub’ for the implementation of international scientific and strategic

developments related to knowledge transfer, the concept of evidence-based

medicine and the role systematic reviews can play for both. It supports the

implementation of methods related to the concepts of evidence-based health

research and the grading of evidence according to the GRADE approach. Another

scientific focus is the investigation of the extent of dissemination bias in medical

research and how it affects the reliability of the results of research syntheses.

Cochrane Germany – Annual Report 2015

4/37

CG was formally registered within the Cochrane Collaboration in 1997. Up to 2004 it

received funding from the German Federal Ministry of Education and Research,

which was complemented by the Medical Center of the University of Freiburg and the

Medical Faculty of the University of Freiburg. Since January 2005 the German Federal

Ministry of Health has sponsored the CG and will continue until the end of 2016.

In 2014, the Medical Center of the University of Freiburg established the Center as a

stand-alone department (Centre for Evidence in Medicine /Cochrane Germany) and

committed to funding Cochrane Germany with a funding perspective for the next five

years. The possibility of establishing a ´German Cochrane Institute` with a full

professorship for systematic reviews is being explored.

A discussion and a parliamentary hearing about the importance of the Cochrane

entities in Germany were stimulated by a comprehensive review of Cochrane

Germany. The review was commissioned by the German Ministry of Health and

conducted by PROGNOS AG1. The final report of this review contains structured

planning methods used to evaluate the strengths, weaknesses, opportunities and

threats involved (SWOT Analysis) for CG. As a result there are ongoing negotiations

about opportunities for an institutional funding of CG by the German Federal

government.

1 https://www.bundesgesundheitsministerium.de/fileadmin/dateien/Publikationen/Gesundheit/

Forschungsberichte/140926-Bericht_Evaluation_DCZl.pdf

Cochrane Germany – Annual Report 2015

5/37

Funding

In 2015 Cochrane Germany received institutional funding from the University Medical

Center Freiburg and the Medical Faculty of the University Freiburg, complemented by funds from the Baden-Württemberg Ministry of of Science, Research and Arts.

Additionally Cochrane Germany raised third party research funds (project funds) to

the amount of Euros 477.000.

CG objectives in 2015

The objectives of CG in 2015 were:

1. Fulfilling the Core Functions of a Cochrane Centre

2. Supporting the activities of the GRADE Working Group and fulfilling the

function of a GRADE Centre in Germany

3. Recruiting and supporting reviewers / review groups

4. Participating in systematic review activities, evidence assessments and HTA

reports

5. Developing and conducting education and training, workshops and courses

related to evidence based medicine, systematic reviews and the GRADE

methodology

6. Improving the quality of publications of clinical trials in German journals by

promoting publication guidelines

7. Information for users of evidence for different target groups (science

journalists, health system professionals, consumers and the public)

8. Maintaining information structures

9. Searching German printed publications for unpublished clinical trials

(Handsearching)

10. Consolidation of the funding for CG

The objectives were accomplished by the following projects, workshops and events, publications and presentations, and further related activities:

Projects in 2015 (selection)

In 2015 CG conducted a total of 6 funded projects with an overall funding volume of

€ 477,000. Briefly, the major projects were (listed in alphabetical order):

ACQuire – funded by the Federal Ministry of Health

Cochrane Germany – Annual Report 2015

6/37

This project (German title: Aktivitäten des Deutschen Cochrane Zentrums mit Fokus

auf der Stärkung der Methoden-Kompetenz in der Leitlinienerstellung sowie in den

Gesundheitsfachberufen zur Verbesserung der Qualität und Evidenzbasierung in der

Gesundheitsversorgung) aims to strengthen the methodical expertise in the

development of clinical guidelines and in the health professions to improve the

quality and evidence base in the healthcare provision.

The project started in January 2015 and ended in December 2015.

DECIDE – funded by the European Commission

CG is a partner in the international consortium of the EU-project DECIDE (Developing

and Evaluating Communication Strategies to Support Informed Decisions and

Practice Based on Evidence) which aims to improve the dissemination of evidence-

based recommendations by building on the work of the GRADE Working Group to

develop and evaluate methods that address the targeted dissemination of

guidelines. The project ran from June 2011 until the end of 2015.

The DECIDE consortium which is a composition of members of the GRADE Working

Group, will further develop the GRADE approach to ensure effective dissemination of

evidence-based recommendations targeted at the key stakeholders (healthcare

professionals; policymakers and managers; patients and the general public) who

determine activities/decisions in clinical practice. The consortium adapts

stakeholder input from advisory groups, consultations and user testing. This is done

across a wide range of health systems in Europe. The targeted dissemination

strategies that are developed, will be evaluated in randomised trials, refined and

used and evaluated with real guidelines, developed by the DECIDE partners and

other guideline developers, that the project partners support.

Source: www.decide-collaboration.eu

INKA – funded by the German Ministry of Education and Research

This project (German title: “Ein Forschungsprojekt über die Veränderung der

Informationsqualität in der Kommunikationskaskade (INKA) von der medizinischen

Fachpublikation bis zur Rezeption der Medizinberichterstattung durch Ärzte und

Laien”) analyses scientific information on its way from the medical abstract to mass

media contributions and is funded from 2013 until the end of 2016. While the project

partner at the Technical University Dortmund analyses the loss of correct

information from initial scientific reports down to the diffusion into public media, CG

investigates the information behavior and resources of German Physicians in an

exploratory study.

Cochrane Germany – Annual Report 2015

7/37

KSA Thalassemia Guideline – funded by the Saudi Center for Evidence Based Health

Care (EBHC), Ministry of Health, Saudi Arabia

This project aims to develop a national, evidence-based guideline based on

systematic reviews for the treatment of Saudi Arabian patients with thalassemia in

cooperation with the Saudi Center for Evidence Based Health Care (Saudi Arabia),

the McMaster University (Canada) and local experts.

The project started in September 2014 and ended in May 2015.

RARE-Bestpractice – funded by the European Commission

CG is a partner in an international consortium which received EU funding for the

project “Platform for sharing best practices for management of rare diseases: RARE-

Bestpractices” in 2012. The project started in January 2013 and will last until

December 2016. The platform will be used for a comprehensive understanding of the

renewed challenges which are generated by actions and incentives of the European

Commission. It intends to address the following critical questions:

A) How to take better advantage of scientific progress in biomedical research in

ways to translate research results into tangible benefits for rare-disease

patients in a timely manner and to offer high quality information to these

patients and health professionals?

B) How to promote and support a consistent level of healthcare services for rare

disease patients, thus implementing the EU Directive on the application of

patients’ rights in cross-border healthcare?

Source: www.rarebestpractices.eu

Review and Evidence Report - Projects with the Institute for Quality and Efficiency

in Health care (IQWiG).

In 2015 the IQWiG commissioned work to the GCC for supporting the evaluation of

interventions.

Systematic Reviews at CG in 2015

To build capacities and implement the methodological developments and

competences of conducting systematic reviews at CG, the centre’s members were

involved in several review projects as co-authors or expert advisers:

Dersch R, Freitag MH, Schmidt S, Sommer H, Rauer S, Meerpohl JJ: Efficacy and

safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review. Eur J Neurol. 2015 Jun 8. doi: 10.1111/ene.12744. PMID: 26058321

Cochrane Germany – Annual Report 2015

8/37

Dersch R, Sommer H, Rauer S, Meerpohl JJ: Prevalence and spectrum of residual

symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic

review. J Neurol. 2015 Oct 12. DOI: 10.1007/s00415-015-7923-0. PMID 26459093

Grabin S, Antes G, Stark GB, Motschall E, Buroh S, Lampert FM: Cell-assisted

lipotransfer—a critical appraisal of the evidence. Dtsch Arztebl Int 2015; 112: 255–61.

DOI: 10.3238/arztebl.2015.0255. PMID: 25920357

Kunath F, Borgmann H, Blümle A, Keck B, Wullich B, Schmucker C, Sikic D, Roelle C,

Schmidt S, Wahba A, Meerpohl JJ: Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A

systematic review with meta-analysis. BMJ Open. 2015 Nov 13; 5(11):e008217. doi:

10.1136/bmjopen-2015-008217. PMID: 26567252

Kunath F, Grobe HR, Rücker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl

JJ: Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-

releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review. BJU international 2015;116(1):30-36.

DOI: 10.1111/bju.13026. PMID: 25523493

Scherer RW, Ugarte-Gil C, Schmucker C, Meerpohl JJ: Authors report lack of time as

main reason for unpublished research presented at biomedical conferences: a

systematic review. J Clin Epidemiol. 2015 Feb 13. pii: S0895-4356(15)00065-7. doi:

10.1016/j.jclinepi.2015.01.027. PMID: 25797837

Schmucker CM, Rücker G, Sommer H, Virgili G, Loke YK, et al.: Treatment as

Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. PLoS ONE

2015, 10(9): e0137866. doi: 10.1371/journal.pone.0137866. PMID: 26368921

Schmucker C, Rücker G, Sommer H, Motschall E, Agostini HJ, Ehlken C: im Namen

des Deutschen Cochrane Zentrums, Universitätsklinikum Freiburg, 2014, im Auftrag

des GKV-Spitzenverbandes. Eine Bewertung des OCT-Verfahrens in den Indikationen

Neovaskuläre Altersabhängige Makuladegeneration und Diabetische Retinopathie: Eine Systematische Übersichtsarbeit. DOI:

10.13140/RG.2.1.3430.6722. https://www.g-ba.de/downloads

Weitz M, Strahm B, Meerpohl JJ, Schmidt M, Bassler D: Extracorporeal

photopheresis versus alternative treatment for chronic graft-versus-host disease

after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database of Systematic Reviews 2015 Dec 15; 12: CD009898. doi:

10.1002/14651858.CD009898.pub3. Review. PMID: 26666581

Weitz M, Strahm B, Meerpohl JJ, Schmidt M, Bassler D: Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after

haematopoietic stem cell transplantation in paediatric patients. Cochrane Database

Cochrane Germany – Annual Report 2015

9/37

of Systematic Reviews 2015 Dec 15; 12: CD009759. doi:

10.1002/14651858.CD009759.pub3. Review. PMID: 26666580

In 2015, the overall publication impact factor of Cochrane Germany as a department of the Medical Center of the University of Freiburg was 35.

Protocols at CG in 2015

Gaertner J, Siemens W, Antes G, Meerpohl JJ, Xander C, Schwarzer G, Stock S, Becker

G: Specialist palliative care services for adults with advanced, incurable illness in

hospital, hospice, or community settings--protocol for a systematic review. Systematic

Review 2015 Sep 25;4:123. doi: 10.1186/s13643-015-0121-4. PMID 26407847

Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe LM, Dersch R, Jensen K, Dahm P,

Meerpohl JJ: Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1

bladder cancer (Protocol). Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD011935. DOI: 10.1002/14651858.CD011935.

Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D: Use of inhaled

corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol. Systematic Review. 2015 Sep 25;

4(1):127. doi: 10.1186/s13643-015-0108-1. PMID 26420776

International Activities & Networking

In 2015, staff of CG was involved in the work of several Cochrane entities and other

international initiatives:

- Screening and Diagnostic Methods Group & Statistical Methods Group &

Working Group ‘Evidence Aid’ (Gerd Antes)

- Advisory Board of the Joanna Briggs Institute, Adelaide, Australia (Gerd Antes)

- Advisory Board of the Cochrane Collaboration and responsible for plenary

session at the Cochrane Colloquium in Vienna (Gerd Antes)

- Cochrane Prognosis Methods Group (Daniela Küllenberg de Gaudry)

- Cochrane Consumer Network – Geographic Advisory Board (Britta Lang)

- Cochrane Nursing Network (Sabine Lins, Sebastian Voigt – Radloff)

- Cochrane Qualitative and Implementation Methods Group (Sabine Lins)

- Cochrane Centre Directors Executive (Joerg Meerpohl, since June 2014)

- Cochrane Steering Group (Joerg Meerpohl, since September 2014).

- Editor in Cochrane Hematological Malignancies Group (Joerg Meerpohl)

- Cochrane Applicability and Recommendations Methods Group (Joerg

Meerpohl)

Cochrane Germany – Annual Report 2015

10/37

- Cochrane Trainers Network (Joerg Meerpohl)

- Advisory Board of Cochrane Child Health Field (Joerg Meerpohl)

- Member of Cochrane Statistical Network (Joerg Meerpohl)

- Member of Cochrane Colloquium Advisory Group (Joerg Meerpohl)

- Cochrane Adverse Effects Methods Group (Christine Schmucker)

Joerg Meerpohl has been engaged in the GRADE Working Group since 2008 and has

been a member of the WHO Nutrition Guidance Expert Advisory Group since 2012.

Gerd Antes was mainly responsible for the translation of the book “Testing

Treatment” from Evans et al. (2015).

Further activities

Collaboration with the Clinical Trials Unit: Promoting the need of systematic reviews as part of an evidence-based study

planning in lectures and workshops (e.g. courses for investigators and

principal investigators)

Scientific consulting of study investigators concerning clinical study planning

in the context of the totality of evidence

Providing support for investigators in identifying all relevant evidence

concerning their specific research question

Development and implementation of training modules for study investigators

concerning systematic literature search and summarizing and presenting the

identified evidence

Implementation of Cochrane rebranding

As part of its 2020 Strategy, Cochrane International introduced a rebrand with new

Cochrane logo, templates for all Cochrane entities around the world and a new look

of Cochrane.org. A set of detailed brand guidelines set out our new brand: who we

are and how we express our identity in the way we look and sound.

At the same time, names of Cochrane Centres were unified and the German Cochrane

Centre was renamed to Cochrane Germany.

Early 2015 we received the new logos for Cochrane Germany as well as the Cochrane

Library,

Old logo - what we used

from 1998 up to 2015: New logos as of 2015

Cochrane Germany – Annual Report 2015

11/37

The Cochrane strapline is the core idea that lies at the heart of everything we do. It

expresses the essential reason why Cochrane exists.

By June 2015, we moved our website to the new look and at the same time

streamlined the contents and improved functionality. Cochrane International

introduced their new website Cochrane.org for their main target users, which now

also provides a second, more comprehensive Community website for Cochrane

insiders and staff. By June, we adapted our website to the corporate identity design

and layout as proposed by Cochrane Central. This entailed streamlined contents and

functionality. Furthermore, Cochrane Central introduced their new website

cochrane.org which is designed to address their target audiences.

Workshops, Training and Events

In the years 2015 CG conducted seven Workshops in Freiburg with an overall number

of participants of 220:

“Systematic Reviews and Introduction to Evidence based Medicine”

05/03/2015-07/03/2015: 45 participants

24/09/2015-26/09/2015: 42 participants

“Systematic Literature Search”

26/03/2015-27/03/2015

Basic and Advanced course: 43 participants

Cochrane Germany – Annual Report 2015

12/37

“GRADE – Grading Evidence into Recommendations”

26/03/2015-27/03/2015

Basic course: 25 participants

Advanced course: 8 participants

”R-Workshop – statistical evaluation beyond RevMan – meta-analysis with R”

26/11/2015-27/11/2015: 26 participants

“Cochrane Reviews: Basic Course for Authors”

21/01/2015-23/01/2015: 31 participants

Joerg Meerpohl established and organized a basic review course for authors together

with the Austrian and Swiss Cochrane branches. This course was hosted for the first

time in Zurich in January 2014 and conducted in Freiburg in January 2015.

We offered a large number of additional workshops and lectures promoting

evidence-based medicine and the Cochrane Library by request:

In-house workshops for scientific journalists

In-house workshop for pharmaceutical students

In-house workshops for guideline organizations

Demonstrations and tutorials of The Cochrane Library

Courses in literature search and methodology in the context of Systematic

Reviews

Cochrane Germany – Annual Report 2015

13/37

Contribution to the “Cochrane Library”: The Cochrane

Central Register of Controlled Trials

Handsearching Project

Handsearching means searching manually for trial publications in printed scientific

medical journals. Each Cochrane Centre searches medical journals, published in

national languages, to identify these reports which otherwise would not be

accessible, because the printed journals are not digitally available or not listed e.g. in

the great biomedical literature databases. This effort increases our knowledge base

of data from clinical trials and tries to overcome barriers leading to publication bias

(by source, medium or language) in systematic reviews. The results of this process

are submitted to the Cochrane Central Register of Controlled Trials (CENTRAL) which

meanwhile contains over 920,000 citations of controlled clinical trials – far more than

accessible via PubMed or EMBASE (Excerpta Medica Database). In the last 15 years

CG identified more than 20.000 study publications, of which nearly 50 % are not

listed in MEDLINE and therefore not easily detectable for scientific research.

Cochrane Germany contributed to this process by submitting in total to CENTRAL

(one component of the Cochrane Library, see also: www.thecochranelibrary.com):

Publishes Studies found,

total since 1998

Number of these published studies listed

in Medline, total since 1998

CCT RCT Total CCT RCT Total

9.488 12.535 22.023 3.678 5.393 9.071

Published studies identified

in 2012

Number of the identified studies 2012

listed in Medline

CCT RCT Total CCT RCT Total

126 279 405 7 91 98

CCT = Controlled Clinical Trial

RCT = Randomised Controlled Trial

Handsearching has been on hold in 2013 and 2014 due to lack of resources and has

been taken up again in 2015. One or two journals from five medical disciplines (allergology, sport medicine,

nursing science, paediatrics and ophthalmology) were chosen for the handsearching

Cochrane Germany – Annual Report 2015

14/37

project. These journals are relevant for German physicians and are not indexed in

MEDLINE.

Table 1 shows the number of original articles and abstracts (separated into CCTs and

RCTs) which are not listed in MEDLINE and which were found by handsearching in the five selected medical journals.

Searched journals (2012-2014) Original articles Abstracts

In total

CCT RCT Gesamt CCT RCT Gesamt

Allergologie 0 0 0 0 2 2 2

Deutsche Zeitschrift für Sportmedizin 3 8 11 25 96 121 132

Pflege und Gesellschaft 0 0 0 0 0 0 0

Pflegewissenschaft 0 0 0 0 0 0 0

Pädiatrische Praxis 0 1 1 0 0 0 1

Spektrum der Augenheilkunde 0 2 2 8 33 41 43

In total 3 11 14 33 131 164 178

Table 1: Original articles or abstracts not listed in MEDLINE

EMBASE Search Project

In 2015 CG contributed to the EMBASE-Screening-Project of the Cochrane Collaboration. EMBASE is a database that covers worldwide literature, especially

from Europe, in the field of human medicine and related fields with special emphasis

given to drug research, pharmacology, pharmacy, pharmacoeconomics, toxicology, basic biological research, health policy and management, public, occupational and

environmental health, and substance dependence and abuse.

The project's purpose is to identify reports of RCTs and quasi-RCTs from EMBASE for publication in CENTRAL. At this time (as of January 2016), 15 % of all citations in

CENTRAL are from EMBASE (compared to 60 % from MEDLINE, 25 % from other

databases). In 2015 CG has screened in total 1,040 studies.

Cochrane Germany – Annual Report 2015

15/37

Cochrane in Germany

Published protocols and reviews

The efforts of CG, the German Review Groups (see below) and the Germany-based

Cochrane working groups (http://www.cochrane.de/de/cochrane-deutschland) as

well as the contributing people in Germany lead to the fact that the number of

corresponding authors in Germany, contributing to Cochrane Reviews, increased

from 542 in 2010, to 691 in 2013, and to 932 in 2016 (as of April 2016) (Search filter:

Country: Germany; Reference centre: CG; Role: Author). Therefore the number of

corresponding authors in Germany has doubled since 2010. That fact highlights the

increased support of German Cochrane personnel in the conduction of reviews.

At the same point of time CG was given as reference centre by 2,368 persons (Search

filter: Reference centre: CG). 588 (2013: 532) come from Switzerland, 213 (2013: 186)

from Austria, 34 (2013: 31) from the Czech Republic 7 (2013: 0) from Slovakia and 37

(2013: 35) from Hungary, 1 (2013: 1) from Liechtenstein (Source: ARCHIE, Cochrane

author’s database, search from 21.04.2016).2

Figure 1 shows the number of reviews and protocols with Germany as the country of origin. Until April 2016 there exist 165 reviews and protocols from Germany.

Figure 1:

Number of Reviews and Protocols with Germany as ‘country of origin’ since 1998

2 From 2.134 persons remain 1.349 with residency in countries other than the reference countries.

Cochrane Germany – Annual Report 2015

16/37

The production of reviews with corresponding authors in Germany shows a

continuous increase from 1998 until the beginning of 2016. Figure 2 shows the

number of published systematic reviews and protocols from Germany, Switzerland,

Austria, Liechtenstein, Hungary and the Czech Republic in 2015. From the last report

there is an increase of published reviews from 153 to 165 in Germany, 19 to 25 in

Austria, 108 to 110 in Switzerland. No changes in comparison to the last year can be

seen in the number of reviews and protocols for Liechtenstein, Hungary, Slovakia

and the Czech Republic.

Figure 2: Number of Full Reviews and Protocols published in the Cochrane Library,

Issue 14, 2016.

Website access

http://www.cochrane.de In 2015, we had 109,384 sessions from 76,041 visitors in total using 331,240 pages.

One third of all visitors were returning.

Figure 3: Homepage visitors and visited sites in 2015

Cochrane Germany – Annual Report 2015

17/37

Our Top 5 of most visited pages (all pages in German language):

1. Welcome (see figure 4) 2. Glossary

3. From evidence to recommendations

4. Events (workshops) 5. Cochrane Library

Figure 4: Start page von Cochrane Deutschland

Cochrane Germany – Annual Report 2015

18/37

Cochrane Review Groups based in Germany

Cochrane Haematological Malignancies Group Dr. Nicole Skoetz, Co-ordinating Editor

University of Cologne, Klinik I für Innere Medizin, 50924 Köln, Germany

Email: info@chmg.de

Web: http://hm.cochrane.org/de/willkommen

The CHMG deals with the evaluation of the diagnosis and treatment of adults with

haematological diseases. The main focus is on leukaemia and lymphoma and the

care of those suffering from other haematological diseases like aplastic anaemia is

also included in the wider scope of the group. In addition, the group evaluates

interventions affecting the haematological cell system like stem cell transplantation

and haemotopoetic growth factors. Finally, supportive care and the management of

haematological diseases also are tasks of the Cochrane Haematological Malignancies

Group.

Cochrane Metabolic and Endocrine Disorders Group Prof. Dr. med. Bernd Richter, Co-ordinating Editor

Department of General Practice, University Hospital Düsseldorf,

Heinrich Heine University, PO Box 101007, D - 40225 Düsseldorf, Germany

E-mail: richterb@uni-duesseldorf.de

Web: http://endoc.cochrane.org/de/willkommen

Since 2000, the CMED has been preparing systematic reviews on the benefits and

harms of healthcare interventions for metabolic and endocrine disorders,

particularly diabetes mellitus and obesity. The CMED's main area of work is the

evaluation of the effects of health care interventions relevant to the prevention,

treatment or management, and rehabilitation of metabolic, nutritional and

endocrine disorders. The CMED expanded its scope to systematic reviews of

diagnostic test accuracy within the same topic areas. The CMED primarily focuses on

systematic reviews which evaluate patient-orientated outcomes measures. Authors

who wish to analyse surrogate outcomes like laboratory parameters may do so but

always have to investigate a standard set of patient-orientated endpoints. Exclusive

evaluation of surrogate indicators only will not be possible.

Cochrane Germany – Annual Report 2015

19/37

Branches of Cochrane Germany

Austrian Cochrane Branch The Austrian Cochrane Branch opened in December 2010 as part of the Department

for Evidence based Medicine and Clinical Epidemiology of the Danube University

Krems. Main tasks are:

It provides the basis for evidence-based decisions in the Austrian health

system.

It is supported by Austrian scientists, who provide the means to create

science-based and independent medical information in the form of Cochrane

Reviews that are available to the Austrian health care and the public.

It promotes the publication of the Cochrane Collaboration and its importance

in the public, aiming at transferring research findings into health care and thereby improving patient information.

It organises workshops for those interested, such as (future, potential)

authors of Cochrane reviews as well as employees of the Cochrane

Collaboration.

It is the first point of contact for people interested as well as for employees of

the Cochrane Collaboration in Austria.

It functions as a contact for employees of the Cochrane Collaboration

worldwide, and thus facilitates the communication within the Cochrane Collaboration.

The Austrian Cochrane Branch is funded by a grant from the Lower Austrian Health and Social Fund (NÖGUS) and supported by the Danube University Krems.

Contact:

Austrian Cochrane Branch (ACB)

Danube University Krems

Department for Evidence-Based Medicine and Clinical Epidemiology Dr.-Karl-Dorrek-Straße 30

A-3500 Krems an der Donau

Austria

Phone: +43 (0)2732 893-2918

Fax: +43 (0)2732 893-4910

E-Mail: office@cochrane.at

Internet: www.cochrane.at

Cochrane Germany – Annual Report 2015

20/37

Swiss Cochrane Branch The Swiss Cochrane Centre is the branch that is supported by the German, the French, and the Italian Cochrane centres. It is a national network which is located in

Lausanne, Switzerland. The goals of the branch are:

Promotion of evidence-based medicine and the activities of the Cochrane

Collaboration. Cochrane Switzerland supports free access to the Cochrane

Library for people in Switzerland

Information of health care professionals and a broader audience about the usage and the benefits of systematic reviews

Promotion of projects for creation and updating of systematic reviews

referring to questions of the effectiveness of medical interventions.

The Swiss Cochrane Branch is funded by the “Institut Universitaire de Médecine

Sociale et Préventive (IUMSP), CHUV” and the “Université de Lausanne”.

Contact:

Cochrane Switzerland

Insitute of Social and Preventive Medicine Centre Hospitalier Universitaire Vaudois and University of Lausanne

Biopôle 2

Route de la Corniche 10 CH-1010 Lausanne

Switzerland

Phone: 0041 21 314 72 55

Fax: 0041 21 314 49 54

Email: bernard.burnand@chuv.ch

Homepage: www.swiss.cochrane.org

Cochrane Germany – Annual Report 2015

21/37

Hungarian Cochrane Branch The negotiations of establishing a Hungarian Cochrane Branch resulted successfully in the official opening of the Branch in October 2014 at the Medical Center of the

University of Pécs. Director of the branch is Prof. Dr. Tamás Decsi and the scientific

coordinator is Dr. Szimonetta Lohner. The goals of the branch are:

to provide information about Cochrane and participate in its international

activities

to train and build capacity for the preparation of systematic reviews, including the preparation and updating of high-quality Cochrane systematic

reviews

to provide language-specific services: e.g. extracting data from Hungarian

papers for Cochrane reviews and translating review summaries into

Hungarian

to disseminate the results of Cochrane reviews in Hungary and to support the

use of Cochrane reviews by specific user groups

to facilitate knowledge transfer of high quality healthcare evidence through formal and informal partnerships with relevant stakeholders in Hungary

to promote access to the Cochrane Library and to Cochrane systematic

reviews.

Contact:

Hungarian Branch of the German Cochrane Centre

University of Pécs HU-7623 Pécs

Rákóczi út 2.

Hungary

Phone: 0036 72 504 226

or: 00+36 72 536 000 / 33026 Email: cochrane@pte.hu

Homepage: http://www.cochrane.pte.hu

Cochrane Germany – Annual Report 2015

22/37

Staff in 2015

Scientific Staff Gerd Antes Director 100 %

Joerg J. Meerpohl Co-Director 100 %

Anette Blümle Senior Researcher &

Trial Search Coordinator 100 %

Claudia Bollig Junior Researcher 100 %

Anne Göhner (until 05/15) Junior Researcher 20 %

Daniela Küllenberg de Gaudry (maternity leave from 05/15 – 04/2016)

Senior Researcher 50 %

Katharina Kunzweiler (since 05/15) Junior Researcher 20 %

Britta Lang (100 % since 10/2015) Senior Researcher 70 %

Christine Schmucker Senior Researcher 75 %

Harriet Sommer Junior Researcher 20 %

Ingrid Töws Junior Researcher 100 %

Sebastian Voigt-Radloff Senior Researcher 50 %

Research Associates with external funding Rick Dersch Research Associate 100 %

Roman Allert (since 09/15) Research Associate 100 %

Gabriel Torbahn (since 09/15) Research Associate 100 %

Administration and Assistance Jasmin Gauch (until 08/15) Administrator 100 %

Christa Bast Administrator, Website Editor 40 %

Georg Koch Systems Administrator 50 %

Stefanie Keller (since 12/15) Administrator 100 %

Inga Nolle (since 12/2015) Student Assistant (hourly work)

Laura Rehner (since 05/15) Student Assistant (hourly work)

Patrick Oeller (until 07/15) Student Assistant (hourly work)

Laura Weißbach (until 08/15) Student Assistant (hourly work)

Tobias Leiblein (since 05/15) Student Assistant (hourly work)

Cochrane Germany – Annual Report 2015

23/37

CG hosts central staff of the Cochrane Collaboration:

The Central Executive Team Chris Mavergames Director of Web Development

Martin Janczyk Web Developer

Paolo Rosati Web Developer

The Cochrane Operations Unit and Cochrane Innovations Satellite in

Freiburg: Lucie Binder (COU) Senior to the CEO of Cochrane

Juliane Ried (Innovations) Translations Coordinator

Cochrane Germany – Annual Report 2015

24/37

Publications of the CG staff in 2015

Scientific Publications

1. Carrasco-Labra A, Brignardello-Petersen R, Santesso N, Neumann I, Mustafa

RA, Mbuagbaw L, Ikobaltzeta IE, De Stio C, McCullagh LJ, Alonso-Coello P, Meerpohl JJ, Vandvik PO, Brozek JL, Akl EA, Bossuyt P, Churchill R, Glenton C,

Rosenbaum S, Tugwell P, Welch V, Guyatt G, Schünemann H: Comparison

between the standard and a new alternative format of the Summary-of-Findings tables in Cochrane review users: study protocol for a randomized

controlled trial. Trials. 2015 Apr 16;16(1):164. PMID: 25873338

2. Dersch R, Toews I, Sommer H, Rauer S, Meerpohl JJ: Methodological quality of guidelines for management of Lyme neuroborreliosis. BMC Neurol. 2015 Nov

25;15(1):242. doi: 10.1186/s12883-015-0501-3. PMID: 26607686

3. Dersch R, Freitag MH, Schmidt S, Sommer H, Rauer S, Meerpohl JJ: Efficacy

and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review. Eur J Neurol. 2015 Jun 8. doi: 10.1111/ene.12744. PMID:

26058321

4. Dersch R, Sommer H, Rauer S, Meerpohl JJ: Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological

treatment: a systematic review. J Neurol. 2015 Oct 12. DOI: 10.1007/s00415-

015-7923-0. PMID 26459093 5. Gaertner J, Siemens W, Antes G, Meerpohl JJ, Xander C, Schwarzer G, Stock S,

Becker G: Specialist palliative care services for adults with advanced,

incurable illness in hospital, hospice, or community settings--protocol for a

systematic review. Syst Rev. 2015 Sep 25;4:123. doi: 10.1186/s13643-015-0121-

4. PMID 26407847

6. Grabin S, Antes G, Stark GB, Motschall E, Buroh S, Lampert FM: Cell-assisted

lipotransfer—a critical appraisal of the evidence. Dtsch Arztebl Int 2015; 112: 255–61. DOI: 10.3238/arztebl.2015.0255. PMID: 25920357 deutsch | englisch

7. Harder T, Abu Sin M, Bosch-Capblanch X, Bruno Coignard, de Carvalho Gomes

H, Duclos P, Eckmanns T, Elder R, Ellis S, Forland F, Garner P, James R, Jansen A, Krause G, Lévy-Bruhl D, Morgan A, Meerpohl JJ, Norris S, Rehfuess E,

Sánchez-Vivar A, Schünemann H, Takla A, Wichmann O, Zingg W, Zuiderent-

Jerak T. Towards a framework for evaluating and grading evidence in public

health. Health Policy. 2015 Mar 23. pii: S0168-8510(15)00055-X. doi: 10.1016/j.healthpol.2015.02.010. PMID: 25863647

8. Küllenberg de Gaudry D, Blümle A, Sommer H, Steinau S, Lindenberg J, Antes

G, Niemeyer C, Meerpohl JJ: Studien und Publikationspraxis in der Pädiatrischen Hämatologie und Onkologie in Deutschland - Analyse der Jahre

1970-2006. [Studies and Publication Practice in Pediatric Hematology and

Oncology in Germany - An Analysis of the Period 1970-2006.] Klin Padiatr. 2015;227(6-07):339-49. doi: 10.1055/s-0035-1565085. PMID: 26600177

9. Küllenberg de Gaudry D, Grede N, Motschall E, Lins S: Analysis of German

nutrition brochures for pregnant women with evidence-based patient

Cochrane Germany – Annual Report 2015

25/37

information criteria. Patient Educ Couns. 2015;98(2):207–212. doi:

10.1016/j.pec.2014.10.015. PMID: 25468390

10. Kunath F, Borgmann H, Blümle A, Keck B, Wullich B, Schmucker C, Sikic D,

Roelle C, Schmidt S, Wahba A, Meerpohl JJ: Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced

prostate cancer A systematic review with meta-analysis. BMJ Open. 2015 Nov

13;5(11):e008217. doi: 10.1136/bmjopen-2015-008217. PMID: 26567252 11. Kunath F, Grobe HR, Rücker G, Motschall E, Antes G, Dahm P, Wullich B,

Meerpohl JJ: Non-steroidal antiandrogen monotherapy compared with

luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review.

BJU international 2015;116(1):30-36. DOI: 10.1111/bju.13026. PMID: 25523493

12. Linde K, Kriston L, Rücker G, Jamil S, Schumann I, Meissner K, Sigterman K,

Schneider A: Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-

Analysis. Ann Fam Med, 2015; 13: 69-79. : http://dx.doi.org/10.1370/afm.1687

13. Meerpohl JJ, Schell LK, Bassler D, Gallus S, Kleijnen J, Kulig M, La Vecchia C, Marušić A, Ravaud P, Reis A, Schmucker C, Strech D, Urrútia G, Wager E, Antes

G, OPEN project consortium: Evidence-informed recommendations to reduce

dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international

consensus meeting. BMJ Open. 2015 May 5;5(5):e006666. doi:

10.1136/bmjopen-2014-006666. PMID: 25943371

14. Pai M, Iorio A, Meerpohl JJ, Taruscio D, Laricchiuta P, Mincarone P, Morciano C, Leo CG, Sabina S, Akl E, Treweek S, Djulbegovic B, Schunemann H:

Developing methodology for the creation of clinical practice guidelines for

rare diseases: A report from RARE-Bestpractices. Rare Diseases 2015;3(1):e1058463. DOI: 10.1080/21675511.2015.1058463

15. Rosenthal R1, Kasenda B, Dell-Kuster S, von Elm E, You J, Blümle A,

Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl

EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A,

Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik

PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M: Completion and Publication Rates of

Randomized Controlled Trials in Surgery: An Empirical Study. Ann Surg.

2015;262(1):68-73. doi: 10.1097/SLA.0000000000000810. PMID: 24979608 16. Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y,

Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen

KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy

V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter

MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel

M, Kasenda B: DISCO study group. Planning and reporting of quality-of-life outcomes in cancer trials. Ann Oncol. 2015 Nov 25. pii: mdv559. PMID:

26612098

Cochrane Germany – Annual Report 2015

26/37

17. Schandelmaier S, von Elm E, You JJ, Blümle A, Tomonaga Y, Lamontagne F,

Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen

KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun

X, Bassler D, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B,

Schwenkglenks M, Hemkens LG, Cook DJ, Meade MO, Bucher HC, Kasenda B,

Briel M: Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study. Crit Care Med. 2015 Oct 14.

DOI: 10.1097/CCM.0000000000001369. PMID 26468895

18. Scherer RW, Ugarte-Gil C, Schmucker C, Meerpohl JJ: Authors report lack of time as main reason for unpublished research presented at biomedical

conferences: a systematic review. J Clin Epidemiol. 2015 Feb 13. pii: S0895-

4356(15)00065-7. doi: 10.1016/j.jclinepi.2015.01.027. PMID: 25797837

19. Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe LM, Dersch R, Jensen K, Dahm P, Meerpohl JJ: Intravesical bacillus Calmette-Guérin versus mitomycin

C for Ta and T1 bladder cancer (Protocol). Cochrane Database of Systematic

Reviews 2015, Issue 11. Art. No.: CD011935. DOI: 10.1002/14651858.CD011935. 20. Schmucker CM, Rücker G, Sommer H, Virgili G, Loke YK, et al.: (2015)

Treatment as Required versus Regular Monthly Treatment in the Management

of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. PLoS ONE 10(9): e0137866. doi: 10.1371/journal.pone.0137866.

PMID: 26368921

21. Shinwell ES, Portnov I, Meerpohl J, Karen T, Bassler D: Use of inhaled

corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol. Syst Rev. 2015 Sep

25;4(1):127. doi: 10.1186/s13643-015-0108-1. PMID 26420776

22. Stegert M, Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Briel M, DISCO study group: An analysis of protocols

and publications suggested that most discontinuations of clinical trials were

not based on preplanned interim analyses or stopping rules. J Clin Epidemiol. 2015 Jun 4. pii: S0895-4356(15)00267-X. doi: 10.1016/j.jclinepi.2015.05.023.

PMID: 26361993

23. Weitz M, Strahm B, Meerpohl JJ, Schmidt M, Bassler D: Extracorporeal

photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

Cochrane Database Syst Rev. 2015 Dec 15;12: CD009898. doi:

10.1002/14651858.CD009898.pub3. Review. PMID: 26666581 24. Weitz M, Strahm B, Meerpohl JJ, Schmidt M, Bassler D: Extracorporeal

photopheresis versus standard treatment for acute graft-versus-host disease

after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database Syst Rev. 2015 Dec 15;12: CD009759. doi:

10.1002/14651858.CD009759.pub3. Review. PMID: 26666580

Cochrane Germany – Annual Report 2015

27/37

Short Communications (Letters, Editorials, Opinion, others)

1. Antes G: Die großen Heimlichtuer. Frankfurter Allgemeine Zeitung. 15.04.2015. 2. Antes G: Forschung darf kein Selbstzweck sein. Innovare: 42-43.

3. Antes G: Impulse für die Wissenschaft - Ergebnisse schneller nutzen. BKK Magazin 2015; 04: 50-55.

4. Antes G: Big Data, Innovation, Personalisierte Medizin und Co. – Sind dies die

Markenzeichen einer neuen Wissenschaft-(lichkeit) in der Medizin? (Essay). Laborjournal 10/2015. > English version: Antes G: A new Science(ability)? Lab

Times Online 2015.

5. Hecht H, Berner MM, Rüther A, Antes G, Berger M: Lehrbuchgestaltung im

Sinne von EbM und Cochrane Collaboration. In: Berger M (Hrsg.). Psychische Erkrankungen (5. Auflage). München: Elsevier, Urban & Fischer: 3-15.

6. Heilmann C, Blümle A: Systematic reviews and meta-analyses: black boxes of

medical literature? European Journal of Cardio-Thoracic Surgery 2015; 1-2. DOI: 10.1093/ejcts/ezv324. PMID: 26374870

7. Lang B: Wissen, was (wirklich!) hilft – medizinisches Wissen auf dem

Prüfstand, Die Ärztin 2015; 62(3):7. 8. Lang B, Toews I, Antes G, Grundmann RT, Schröer-Günther M: Evidenzbasierte

Gefäßchirurgie – von der Forschung in die Praxis. Gefäßchirurgie 2015:1-5.

DOI: 10.1007/s00772-015-0047-0.

9. Lang B: Die Spreu vom Weizen trennen - Wie finde ich verlässliche Gesundheitsinformationen im Internet? Kompass Gesundheit 4 (1): 20-21.

10. Lelgemann M, Wild C, Antes G, Edler L, Edzard E, Gaertner J:Nicht haltbare

Behauptungen (zu dem Beitrag "Lebensqualität von Patienten mit fortgeschrittenem Pankreaskarzinom unter Misteltherapie: Eine

randomisierte kontrollierte Studie"). Deutsches Ärzteblatt. 2015; 112 (1-2): 10-

11. http://10.3238/arztebl.2015.0010b 11. Marusic A, Meerpohl JJ: Recommendations to reduce the incomplete

dissemination of research findings from clinical trials. Newsletter no. 1 . June

2015. Netherlands Research Integrity Network.

12. Moher D, Avey M, Antes G, Altman DG: The National Institutes of Health and guidance for reporting preclinical research. BMC Med. 2015 Feb 17;13(1):34.

doi: 10.1186/s12916-015-0284-9. PMID: 25775278

13. Negrini S, Kiekens C, Meerpohl JJ, Thomson D, Zampolini M, Christodoulou N, Delarque A, Gutenbrunner C, Michail X: Contributing to the growth of Physical

and Rehabilitation Medicine (PRM): call for a Cochrane Field in PRM. Eur J

Phys Rehabil Med. 2015 Jun;51(3):239-43.PMID: 25986225

14. Schmidt S, Kunath F, Kranz J, Zengerling F, Drager DL, Kroger N, Krabbe LM,

Miernik A, Borgmann H, Spek A, Meerpohl JJ, Dahm P, Wullich B: [Overcoming

the language barrier: UroEvidence translates Cochrane abstracts]. Der

Urologe Ausg A 2015;54(1):76-7. DOI: 10.1007/s00120-014-3750-7. PMID: 25519997

15. Schmucker C: Medikamente gegen den Sehschärfeschwund (Interview).

Apotheken Umschau 1. Januar 2015 A: 21.

Cochrane Germany – Annual Report 2015

28/37

16. Schmucker C, Rücker, G, Sommer H, Motschall E, Agostini HJ, Ehlken C: im

Namen des Deutschen Cochrane Zentrums, Universitätsklinikum Freiburg,

2014, im Auftrag des GKV-Spitzenverbandes. Eine Bewertung des OCT-

Verfahrens in den Indikationen Neovaskuläre Altersabhängige Makuladegeneration und Diabetische Retinopathie: Eine Systematische

Übersichtsarbeit. DOI: 10.13140/RG.2.1.3430.6722. https://www.g-

ba.de/downloadsToews I, Antes G: 2015. Wie glaubwürdig ist die Evidenz? Swiss Medical Forum 15(38):832–839.

17. Türp J, Antes G: Der Zeitschriften-Impact-Faktor. Deutsche Zahnärztliche

Zeitschrift 2015; 4: 242-49. 18. Voigt-Radloff S, Lang B: Der Forschungs-Praxis-Transfer in den

Gesundheitsfachberufen - von klinischen Studien zur evidenzbasierten Praxis

In: Pundt J, Kälble, K (Hrsg.). Gesundheitsberufe und gesundheitsberufliche

Bildungskonzepte. Bremen: Apollon University Press: 457-80.

Conference Abstracts

1. Blümle A, Schandelmaier S, Oeller P, Kasenda B, Briel M, von Elm E: Premature discontinuation of studies approved by research ethics

committees: a comparison of randomized and non-randomized clinical

studies. 23rd Cochrane Colloqium; 3.-7.10.2015, Vienna, Austria. Cochrane Collaboration.

2. Blümle A, Schandelmaier S, Oeller P, Kasenda B, Briel M, von Elm E:

Premature discontinuation of studies approved by research ethics

committees – a comparison of randomized and non-randomized clinical studies. REWARD/EQUATOR Conference; 28.-30.09.2015, Edinburgh, UK.

Cochrane Collaboration.

3. Bollig C, Suter K, Günther J, Hoppe-Tichy T, Antes G, Lang B: Querschnittsstudie zu Informationsmöglichkeiten und –bedürfnissen von

Schweizer Spitalapothekern. GSASA Kongress 2015; 26.-27.11.2015, Zürich,

Schweiz. 4. Bollig C, Günther J, Suter K, Hoppe-Tichy T, Antes G, Lang B: What German

hospital pharmacists want to know: cross-sectional survey on information

behaviour and information needs. 23. Cochrane Colloqium; 05.10.2015, Wien,

Österreich. 5. Muth C, Aksamit N, von Büdingen F, Motschall E, van den Akker M, Blom J,

Beyer M, Kühlein T, Lang B: Poster #158 - Patientenpräferenzen bei

Multimorbidität und Multimedikation – Pilotierung einer Evidence Map. 49. Kongress für Allgemeinmedizin und Familienmedizin der DEGAM, SÜGAM und

ÖGAM; 18.09.2015, Bozen, Italien.

6. Kasenda B, Amstutz A, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Bengough T, Meerpohl JJ, Stegert M, Olu K, Tikkinen K, Neumann I, Carrasco-

Labra A, Faulhaber M, Mulla S, Mertz D, Akl E, Bassler D, Busse J, Ferreira-

González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Ebrahim S,

Cochrane Germany – Annual Report 2015

29/37

Schandelmaier S, Sun X, Vandvik P, Johnston B, Walter M, Burnand B,

Schwenkglenks M, Kasenda L, Bucher H, Guyatt G, Briel M: Agreements on

publication rights: an investigation of protocols and publications of

randomized clinical trials. 23rd Cochrane Colloqium; 3.-7-10.2015, Vienna, Austria.

7. Kirkham J, Dwan K, Blümle A, von Elm E, Williamson RE: How much study

participant data is missing from our trials? 23rd Cochrane Colloquium; 3.-7.10.2015, Vienna, Austria.

8. Lang B, Wormer H, Serong J, Anhäuser M, Antes G: Veränderung der

Informationsqualität der Kommunikationskaskade (INKA) von der medizinischen Fachpublikation bis zur Rezeption der

Medizinberichterstattung durch Ärzte und Laien (Poster). 16 Jahrestagung

des Deutschen Netzwerks Evidenzbasierte Medizin; 13.03.2015, Berlin.

Deutsches Netzwerk Evidenzbasierte Medizin e.V. 9. Schmucker C, Ehlken C, Rücker G, Antes G, Virgili G: Quality Assessment of

Diagnostic Accuracy Studies after a Modified Version of QUADAS-2 in

Ophthalmological Research. 23rd Cochrane Colloquium 2015; 03.-03.10.2015, Wien, Österreich. Cochrane Deutschland.

10. Sommer H, Rücker G, Schwarzer G, Antes G: Methodik der Metaanalyse. 16.

Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin e.V.; 14.03.2015, Berlin, Deutsches Netzwerk Evidenzbasierte Medizin e.V.

11. Töws I: Cochrane Kompakt – Evidence of Cochrane Reviews in German. 8th

European Public Health Conference - Health in Europe – from global to local

policies, methods and practices; 16.10.2015, Mailand, Italien. 12. Töws I: Awareness and perception of dissemination bias in qualitative

research: an exploratory study. 23rd Cochrane Colloquium Vienna - Filtering

the information overlaod for better decisions; 07.10.2015, Wien, Österreich. 13. Töws I: Strategies for eliciting mutual benefit from translating Cochrane

Review content: the example of Cochrane Kompakt in German. 23rd Cochrane

Colloquium Vienna - Filtering the information overlaod for better decisions; 05.10.2015, Wien, Österreich.

14. Töws I: Author Instructions in Journals of Haematology and Oncology.

Increasing value and reducing waste in biomedical research conference;

29.09.2015, Edinburgh, UK. 15. Voigt-Radloff S: The Cochrane Collaboration. 9th World Congress of the

International Society of Physical and Rehabilitation Medicine; 22.06.2015,

Berlin.

Cochrane Germany – Annual Report 2015

30/37

Presentations of CG staff in 2015

Presentations

1. Albani S, Röspel R, Kühn-Mengel H, Antes G, Krawczak M, Wormer H:

Podiumsdiskussion mit Abgeordneten. Medizinische Forschung: Mehr Wert, weniger Verschwendung - Was können wir tun? 24.09.2015 Berlin.

2. Antes G: Ist das Zeitalter der Kausalität vorbei? IQWiG-Herbst-Symposium -

(Fast) wie im richtigen Leben - "Real World Data" zur Nutzenbewertung?; 27.11.2015, Köln.

3. Antes G: Unabhängige und verlässliche Informationsquellen. GSASA-

Kongress; 26.11.2015, Zürich, Schweiz. 4. Antes G: Festvortrag. 50 Jahre IMIS - Jubiläumssymposium; 13.11.2015, Kiel.

5. Antes G: Evidenz als Entscheidungsinstrument? Medizin&Management 2015 -

Jahrestagung des Weitmoser Kreises - "Besser - oder doch ganz anders!?

Zukunft eines expansiven Gesundheitssystems"; 06.11.2015, Wien, Österreich. 6. Antes G: Englisch? We need to make evidence usage in all languages an

everyday reality. 23rd Cochrane Colloqium Vienna; 03.-07.10.2015, Wien,

Österreich. 7. Antes G: Wissenschaftliches Publishing. 113 DOG Kongress; 1.10.2015, Berlin.

8. Antes G: Randomisierte klinische Studien: ... nicht alles Gold was glänzt?

Neurology First - DGN-Kongress 2015; 25.09.2015, Düsseldorf. 9. Antes G: Globales Wissen und lokale Anwendung - Grundlage für alle

Entscheidungen in der Gesundheitsversorgung. e-day in der

Fachbereichsbibliothek Bühlplatz, Bern; 15.09.2015, Bern, Schweiz.

10. Antes G: Cochrane Collaboration. Cologne Consensus Conference 2015;

11.09.2015, Köln.

11. Antes G: Translational Medicine. Global Knowledge - Local Application.

Vortrag am Zentralinstitut für seelische Gesundheit, Mannheim; 04.08.2015, Mannheim.

12. Antes G: Versorgungsforschung - Garant für eine bessere Versorgung? 2.

Zürcher Forum für Versorgungsforschung; 18.06.2015, Zürich, Schweiz. 13. Antes G: Aim and benefit: All trials registered - all results reported. 13

Bionnale; 27.05.2015, Berlin, Germany. vfa.bio, HealthCapital Berlin

Brandenburg.

14. Antes G: Wie glaubwürdig ist die Evidenz? Bayerischer Apothekertag; 09.05.2015, Amberg

15. Antes G: Alternativlos für erfolgreiche Forschung: Vernetzung, Transparenz

und methodische Qualität (Evening Lecture). 7 TMF-Jahreskongress; 25.03.2015, Hannover, Technologie- und Methodenplattform für die vernetzte

medizinische Forschung.

16. Antes G, Lang B, Toews I: Von Fachpublikationen bis Massenmedien: Eine explorative Studie zur Rezeption medizinisch-wissenschaftlicher Ergebnisse

durch Ärzte und Laien INKA-Symposium; 18.03.2015, Dortmund, TU

Dortmund, Medien-doktor.de.

Cochrane Germany – Annual Report 2015

31/37

17. Antes G: Biostatistik in der Öffentlichkeit I. 61 Biometrisches Kolloquium;

16.03.2015, Hannover, TU Dortmund.

18. Antes G: Hat die Klinische Forschung ein Qualitäts- oder nur ein

Glaubwürdigkeits- und Reputationsproblem? Retraite 2015 der Kantonalen Ethikkommission Zürich; 02.02.2015, Zürich, Schweiz. Kantonale

Ethikkommission Zürich.

19. Antes G: Ist Wissen Macht? Wissen und Wissensmanagement der Partner im Gesundheitswesen. Krankenkassen 2015; 15.01.2015, Berlin, Euroforum.

20. Antes G: Wie glaubwürdig ist die Evidenz? - von verzerrter Publikation bis zur

Fälschung. 4. Kongress zur Arzneimittelforschung; 09.01.2015, Köln 21. Blümle A: Studienplanung im Kontext der bisherigen Evidenz. Vortrag an der

Klinik für Thoraxchirurgie, Universitätsklinikum Freiburg; 21.09.2015,

Freiburg.

22. Blümle A: Studienplanung im Kontext der bisherigen Evidenz. Fachgruppensitzung Aus-, Fort - und Weiterbildung, KKS Netzwerk -

Koordinierungszentren für klinische Studien; 21.09.2015, Frankfurt a. M.

23. Blümle A: Literaturrecherche / (Zahn-)Medizinische Datenbanken und Webportale (einschl. Suchstrategien). Universitätskliniken für Zahnmedizin –

Wissenschaftswoche; 8.09.2015, Basel, Schweiz.

24. Blümle A: Evidence-based Medicine (EbM) and the Cochrane Collaboration. Vortrag am Institute for the International Education Students (IES Abroad),

Universität Freiburg; 20.05.2015, Freiburg.

25. Lang B: Wissen was (wirklich!) hilft - medizinisches Wissen auf dem Prüfstand.

34. Kongress des deutschen Ärztinnenbundes eV (DÄB); 19.09.2015, Düsseldorf.

26. Lehmann I, Rechkemmer G, Antes G, Schaller J: Podiumsdiskussion: Eier, Fett,

Zucker - Ernährungsempfehlungen in Deutschland! - Wie belastbar ist die Ernährungswissenschaft? Mythen und Fakten in der Ernährung:

Journalistenworkshop im Presseclub München; 02.10.2015, München.

27. Meerpohl, J. Einführung systematische Übersichtsarbeiten / Meta-Analysen. in Mitglieder des Vorstands der Dt. Gesellschaft für Virologie. 2015. 16.01.2015,

Freiburg, Deutschland.

28. Meerpohl, J. Ad-o-lopment of guidelines: a way forward for Croatia. in Annual

Symposium Croatian Cochrane Branch. 2015. 11.05.2015, Split, Croatia. 29. Meerpohl, J.J. Overview of the GRADE methodology for assessing the quality

of evidence, and developing and determining the strength of

recommendations in 8th Meeting of the WHO NUGAG Subgroup on Diet and Health. 2015. 09.-12.06.2015; Fukuoka, Japan.

30. Meerpohl, J.J. Einführung in GRADE. in 1. Treffen der Leitlinien-Experten-

Gruppe S3-Leitlinie "Vaginale Geburt am Termin". 2015. 16.06.2015; Frankfurt, Germany.

31. Meerpohl, J.J. Patientenbeteiligung - Welche Evidenz benötigen die

Entscheider: Perspektive der Wissenschaft. in Bundesverband Manged Care

AG Sitzung 2015. 24.09.2015; Berlin, Germany.

Cochrane Germany – Annual Report 2015

32/37

32. Meerpohl, J.J. and C. Nishida. Developing the WHO sugar guideline: Evidence,

process and political influence. in 23rd Cochrane Colloquium. 2015. 03.-

07.10.2015; Vienna, Austria.

33. Meerpohl, J.J. Wie glaubwürdig ist die Evidenz? Von verzerrter Publikation bis zur Fälschung. in 4. Fortbildungskongress, Ärztekammer Berlin. 2015.

05.12.2015; Berlin, Germany.

34. Meerpohl, J.J. (In-)Transparenz in der medizinischen Forschung - Publikationsbias und mehr. in Antrittsvorlesung Privatdozent. 2015.

10.12.2015; Freiburg, Germany.

35. Sauerland, S. and J.J. Meerpohl. Bewertung nicht-randomisierter Interventionsstudien mit dem neuen Bewertungsinstrument ACROBAT-NRSI

der Cochrane Collaboration in 16. Jahrestagung des Deutschen Netzwerks

Evidenzbasierter Medizin e.V. 2015. 13.-14.03.2015, Berlin, Deutschland:

Deutsches Netzwerk Evidenzbasierter Medizin e.V. 36. Schmucker C: Assessing risk of bias in randomised controlled trials (RCTs).

Vortrag am Institute for the International Education Students (IES Abroad),

Universität Freiburg; 20.05.2015, Freiburg. 37. Schmucker C: Systemische Nebenwirkungen der intravitrealen anti-VEGF

Therapie? 99. Jahrestagung der Baden-Württembergischen Augenärztlichen

Vereinigung (BWAW) - (IVOM-Aufbaukurs); 27.02.2015, Freiburg. 38. Voigt-Radloff S: Forschungsmethoden und Empfehlungen in den

Therapiewissenschaften. Studientag der bundesweiten Arbeitsgemeinschaft

"Implementation" der Kreativtherapien (Tanz, Musik, Theater, Kunst);

02.10.2015, Heidelberg. 39. Voigt-Radloff S: Forschungsmethoden und Empfehlungen in den Pflege- und

Therapiewissenschaften. Forum Gesundheit und Pflege - Forschung in den

Gesundheitswissenschaften; 19.06.2015, Mainz. 40. Voigt-Radloff S: Empfehlung für therapiewissenschaftliche Forschungs-

methoden. Keynote Speech zum Thema: Empfehlung für therapiewissen-

schaftliche Forschungsmethoden; 01.05.2015, Mainz.

Workshop Contributions

1. Antes G: Plenarvortrag: Effekte von EbM auf das Gesundheitssystem - die

Perspektive des deutschen Cochrane Zentrum. 16 Aufbaukurs Evidenzbasierte Medizin; 31.08.2015, Lübeck.

2. Antes G: Implementation of medical research in clinical practice. Workshop on

Health Research Strategic Needs in Europe; 13.03.2015, Brussels, Belgium. European Science Foundation.

3. Antes G: Reviews und Review-Methodik in der Praxis: HTA-Berichte, Leitlinien,

Patienteninformation. 32 Workshop "Systematische Übersichtsarbeiten" von Cochrane Deutschland; 07.03.2015, Freiburg.

Cochrane Germany – Annual Report 2015

33/37

4. Antes G: Reviews und Review-Methodik in der Praxis: HTA-Berichte, Leitlinien,

Patienteninformation. 33 Workshop "Systematische Übersichtsarbeiten" von

Cochrane Deutschland; 26.09.2015, Freiburg.

5. Blümle A: Die Cochrane Collaboration. 32. Workshop "Systematische Übersichtsarbeiten". 05.03.2015, Freiburg, Deutschland: Cochrane

Deutschland.

6. Blümle A: Die Cochrane Collaboration. 33. Workshop "Systematische Übersichtsarbeiten". 24.09.2015, Freiburg, Deutschland: Cochrane

Deutschland.

7. Blümle A, Bollig C, Boecker M, Janka H, Buroh S: Praktische Übung: Medline via Pubmed. 33. Workshop „Systematische Übersichtsarbeiten“. 24.09.2015,

Freiburg, Deutschland: Cochrane Deutschland.

8. Blümle A, Töws I, Bollig C, Voigt-Radloff S: Praktische Übungen: Die Cochrane

Library. 33. Workshop „Systematische Übersichtsarbeiten“. 24.09.2015, Freiburg, Deutschland, Cochrane Deutschland.

9. Blümle A: Einführung in die Cochrane Collaboration und die Datenbanken der

Cochrane Library. 9. Workshop "Die systematische Literatur-Recherche" 26.03.2015, Freiburg, Deutschland: Cochrane Deutschland.

10. Blümle A, Metzendorf M.-I., Boeker M, Braun M, Buroh S, Janka H: Übung:

Angeleitet in MEDLINE unter PubMed suchen. 9. Workshop „Die systematische Literatur-Recherche“ 26.03.2015, Freiburg, Deutschland: Cochrane

Deutschland.

11. Bollig C, Boeker M, Metzendorf M.-I., Braun M, Janka H, Buroh S: Praktische

Übung: Medline via Pubmed. 32. Workshop "Systematische Übersichtsarbeiten" 05.03.2015, Freiburg, Deutschland: Cochrane

Deutschland.

12. Bollig C, Töws I, Gechter D, Metzendorf M.-I, Janka H, Hausner E, Lefebvre C: Übung: Freies Üben in Ovid, PubMed, Studienregister, Cochrane Library,

Suchfilter mit Möglichkeit für Rückfragen und Austausch. 9. Workshop „Die

systematische Literatur-Recherche“ 27.03.2015, Freiburg, Deutschland: Cochrane Deutschland.

13. Lang B: Einführung in die evidenzbasierte Medizin mit Fokus Literatur-

Recherche. 9. Workshop "Die systematische Literatur-Recherche". 26.03.2015,

Freiburg, Deutschland: Cochrane Deutschland. 14. Lang B, Bollig C, Töws, I: Übung: Hands-on Übungen: The Cochrane Library. 9.

Workshop „Die systematische Literatur-Recherche“. 26.03.2015, Freiburg,

Deutschland: Cochrane Deutschland. 15. Lang B, Töws I, Bollig C, Gechter D, Metzendorf M.-I., Buroh S, Janka H: Übung:

MEDLINE mit Ovid suchen. 9. Workshop „Die systematische Literatur-

Recherche“. 27.03.2015, Freiburg, Deutschland: Cochrane Deutschland. 16. Lang B, Skoetz N, Wolff R, Schmucker C, Rancea M, Voigt-Radloff S, Bollig C,

Töws I: Gruppenarbeit: Kritische Beurteilung einer randomisierten Studie. 32.

Workshop "Systematische Übersichtsarbeiten" 05.03.2015, Freiburg,

Deutschland: Cochrane Deutschland. 17. Lang B, Schmucker C, Voigt-Radloff S, Bollig C, Metzendorf M.-I: Praktische

Übungen: Die Cochrane Library. 32. Workshop "Systematische

Cochrane Germany – Annual Report 2015

34/37

Übersichtsarbeiten" 05.03.2015, Freiburg, Deutschland: Cochrane

Deutschland.

18. Lang B, Skoetz N, Schmucker C, Voigt-Radloff S, Bollig C, Töws I:

Gruppenarbeit: Kritische Beurteilung einer randomisierten Studie. 33. Workshop "Systematische Übersichtsarbeiten" 25.09.2015, Freiburg,

Deutschland: Cochrane Deutschland.

19. Lang B, Skoetz N, Schmucker C, Voigt-Radloff S, Bollig C: Gruppenarbeit: Kritische Bewertung eines Reviews. 33. Workshop "Systematische

Übersichtsarbeiten" 25.09.2015, Freiburg, Deutschland: Cochrane

Deutschland. 20. Meerpohl JJ, Skoetz N, Töws I: RevMan Cochrane Review Manager. 33.

Workshop "Systematische Übersichtsarbeiten". 25.09.2015, Freiburg,

Deutschland: Cochrane Deutschland.

21. Meerpohl JJ: Qualität der Evidenz. 10. Workshop „GRADE“. 26.03.2015, Freiburg, Deutschland: Cochrane Deutschland.

22. Meerpohl JJ: GRADE Profiler. 10. Workshop „GRADE“. 26.03.2015, Freiburg,

Deutschland: Cochrane Deutschland. 23. Meerpohl JJ, Thaler K: Praktische Übung in Kleingruppen. 10. Workshop

„GRADE“. 26.03.2015, Freiburg, Deutschland: Cochrane Deutschland.

24. Meerpohl JJ: Qualität der Evidenz. 10. Workshop „GRADE“. 26.03.2015, Freiburg, Deutschland: Cochrane Deutschland.

25. Meerpohl JJ, von Elm E, Dersch R, Gartlehner G, Nußbaumer B: Kleingruppen:

Risiko für Bias – Bewertung. Cochrane Reviews: Basiskurs für Autoren.

22.01.2015, Freiburg, Deutschland: Cochrane Deutschland. 26. Meerpohl JJ: Daten extrahieren. Cochrane Reviews: Basiskurs für Autoren.

22.01.2015, Freiburg, Deutschland: Cochrane Deutschland.

27. Meerpohl JJ: Analyse dichotomer Endpunkte. Cochrane Reviews: Basiskurs für Autoren. 22.01.2015, Freiburg, Deutschland: Cochrane Deutschland.

28. Meerpohl JJ: Summary of Findings Tables. Cochrane Reviews: Basiskurs für

Autoren. 22.01.2015, Freiburg, Deutschland: Cochrane Deutschland. 29. Meerpohl, J. GRADE Going from evidence to recommendation / decision. in

GRADE Workshop. 2015. 27.01.2015, Amsterdam, The Netherlands:

Zorginstituut Nederlands.

30. Meerpohl, J. GRADE An Introduction. in GRADE Workshop. 2015. 26.01.2015, Amsterdam, The Netherlands: Zorginstituut Nederlands.

31. Meerpohl, J. Quality of Evidence (aka) Confidence in effect estimates. in GRADE

Workshop. 2015. 26.01.2015, Amsterdam, The Netherlands: Zorginstituut Nederlands.

32. Meerpohl, J. GRADE - Going from evidence to recommendation / decision. in

GRADE Workshop. 2015. 26.01.2015, Amsterdam, The Netherlands: Zorginstituut Nederlands.

33. Meerpohl, J. GRADE - An Introduction. in GRADE Workshop. 2015. 12.01.2015,

Frankfurt, Germany: European Stroke Organization.

34. Meerpohl, J. The GRADE approach - Quality of Evidence (aka) Confidence in effect estimates in GRADE Workshop. 2015. 26.01.2015, Amsterdam, The

Netherlands: Zorginstituut Nederlands.

Cochrane Germany – Annual Report 2015

35/37

35. Meerpohl, J. From evidence to recommendations / decisions. in GRADE

Workshop. 2015. 26.01.2015, Amsterdam, The Netherlands: Zorginstituut

Nederlands.

36. Meerpohl, J.J. Quality of Evidence (aka) Confidence in effect estimates (aka) Certainty of evidence. in GRADE Workshop, S3 Leitlinien "Vaginale Geburt" und

"Kaiserschnitt". 2015. 22.10.2015; Frankfurt, Germany.

37. Meerpohl, J.J. GRADE: Going from evidence to recommendation. in GRADE Workshop, S3 Leitlinien "Vaginale Geburt" und "Kaiserschnitt". 2015.

22.10.2015; Frankfurt, Germany.

38. Meerpohl, J.J. GRADE: Evidence to Decision (EtD) Framework. in GRADE Workshop, S3 Leitlinien "Vaginale Geburt" und "Kaiserschnitt". 2015.

22.10.2015; Frankfurt, Germany.

39. Meerpohl, J.J. GRADE: Quality of Evidence. in WHO GRADE Workshop. 2015. 05.-

06.11.2015; Geneva, Switzerland. 40. Meerpohl, J.J. GRADE: Going from evidence to recommendation. in WHO GRADE

Workshop. 2015. 05.-06.11.2015; Geneva, Switzerland.

41. Meerpohl, J.J. GRADE: Qualität der Evidenz. in GRADE Workshop. 2015. 15.-16.12.2015; Krems, Austria.

42. Meerpohl, J.J. GRADE: Von der Evidenz zur Empfehlung. in GRADE Workshop.

2015. 15.-16.12.2015; Krems, Austria. 43. Meerpohl, J.J. and N. Skoetz. GRADE Workshop II: Von der Evidenz zur

Empfehlung. in 16. Jahrestagung des Deutschen Netzwerks für Evidenzbasierte

Medizin e.V. 2015. 13.-14.03.2015, Berlin, Deutschland: Deutsches Netzwerk für

Evidenzbasierte Medizin e.V. 44. Schmucker C, Voigt-Radloff S, Bollig C, Töws I, Rancea M, Wolff R, Skoetz N:

Gruppenarbeit: Kritische Bewertung eines Reviews. 32. Workshop

"Systematische Übersichtsarbeiten" 07.03.2015, Freiburg, Deutschland: Cochrane Deutschland.

45. Schmucker C: Systematische Übersichtsarbeiten & Risiko für Bias in klinischen

Studien. Fortbildungsreihe an der Augenklinik der Universität Freiburg; 10.07.2015, Freiburg.

46. Schmucker C: Bewertung des Risikos für Bias in klinischen Studien. 33.

Workshop "Systematische Übersichtsarbeiten" 25.09.2015, Freiburg,

Deutschland: Cochrane Deutschland. 47. Schmucker C: Verfassen eines Protokolls. Cochrane Reviews: Basiskurs für

Autoren. 22.01.2015, Freiburg, Deutschland: Cochrane Deutschland.

48. Schmucker C: Suche nach Studien. Cochrane Reviews: Basiskurs für Autoren. 22.01.2015, Freiburg, Deutschland: Cochrane Deutschland.

49. Schmucker C, von Elm E, Gartlehner G, Nußbaumer B: Kleingruppen:

Erarbeiten einer PICO-Frage & Literatursuche. Cochrane Reviews: Basiskurs für Autoren. 22.01.2015, Freiburg, Deutschland: Cochrane Deutschland.

50. Skoetz, N. and J.J. Meerpohl. GRADE Workshop I: Qualitätsbewertung der

Evidenz. in 16. Jahrestagung des Deutschen Netzwerks für Evidenzbasierte

Medizin e.V. 2015. 13.-14.03.2015, Berlin, Deutschland: Deutsches Netzwerk für Evidenzbasierte Medizin e.V.

Cochrane Germany – Annual Report 2015

36/37

51. Sommer H: Analysen / Meta-Analysen I: Effektmaße. 32. Workshop

"Systematische Übersichtsarbeiten". 06.03.2015, Freiburg, Deutschland:

Cochrane Deutschland.

52. Sommer H: Effektmaße & Metaanalysen. 33. Workshop "Systematische Übersichtsarbeiten". 25.09.2015, Freiburg, Deutschland: Cochrane

Deutschland.

53. Sommer H: Grundlegende Methoden der Metaanalyse. Workshop „Statistische Auswertung über RevMan hinaus – Metaanalyse mit R“. 26.11.2015. Freiburg,

Deutschland: Cochrane Deutschland.

54. Töws I, Skoetz N, Wolff R, Dersch R: RevMan Cochrane Review Manager. 32. Workshop "Systematische Übersichtsarbeiten" 06.03.2015, Freiburg,

Deutschland: Cochrane Deutschland.

55. Voigt-Radloff S: Evidenzbasierte Innovationen in den Gesundheitsberufen. 2.

Workshop des wissenschaftlichen Forums Gesundheit (WiFoGe) „Evidenzbasierte Innovationen in den Gesundheitsberufen; 27.-28-10.2015,

Hannover.

56. Voigt-Radloff S: Aufbau von Forschungskapazität und praxisbasierten Forschungsnetzwerken für die Gesundheitsfachberufe. Workshop: Aufbau von

Forschungskapazität und praxisbasierten Forschungsnetzwerken für die

Gesundheitsfachberufe; 26.02.2015, Kiel. 57. Voigt-Radloff S: Evidenzbasierte Innovationen in den Gesundheitsfachberufen.

Workshop; 8.-9.01.2015, Hildesheim.

Teaching/Continuous Medical Education

1. Antes G: Studienplanung unter Berücksichtigung der bereits vorhandenen

Evidenz. Kurs für Mediziner; 20.05.2015, Universitätsklinikum Freiburg, Innere

Medizin I, Freiburg 2. Antes G: Wie glaubwürdig ist die Evidenz? - von verzerrter Publikation bis zur

Fälschung. Fortbildung für Ärzte; 20.05.2015, Department für Innere Medizin,

Universitätsklinikum, Freiburg

3. Blümle A: Publikation, transparente Berichterstattung, CONSORT Statement. Studienleiterkurs des Studienzentrums, Universitätsklinikum Freiburg;

25.11.2015, Freiburg.

4. Blümle A: Evidenzbasierte Medizin, Studienplanung, Literaturrecherche. Studienleiterkurs des Studienzentrums, Universitätsklinikum Freiburg;

24.11.2015, Freiburg.

5. Blümle A: Studientypen. Studienleiterkurs des Studienzentrums,

Universitätsklinikum Freiburg; 23.11.2015, Freiburg.

6. Blümle A: Bewertung von klinischen Studien. Seminar für den Berufsverband

der Allgemeinzahnärzte; 21.11.2015, München.

7. Blümle A: Einführung in die Literaturrecherche. Seminar für den Berufsverband der Allgemeinzahnärzte; 21.11.2015, München.

8. Blümle A: Einführung in die evidenzbasierte (Zahn-)Medizin, Cochrane und die

Cochrane Library. Seminar für den Berufsverband der Allgemeinzahnärzte; 21.11.2015, München.

Cochrane Germany – Annual Report 2015

37/37

9. Blümle A: Studienplanung unter Berücksichtigung der bereits vorhandenen

Evidenz; 18.11.2015, Universitätsklinikum Freiburg, Plastische Chirurgie /

Handchirurgie, Freiburg.

10. Blümle A: Publikation, Transparente Berichterstattung, CONSORT Statement. Studienleiterkurs des Studienzentrums, Universitätsklinikum Freiburg;

24.07.2015, Freiburg.

11. Blümle A: Evidenzbasierte Medizin, Studienplanung, Literaturrecherche. Studienleiterkurs des Studienzentrums, Universitätsklinikum Freiburg;

23.07.2015 Freiburg.

12. Blümle A: Studientypen. Studienleiterkurs des Studienzentrums, Universitätsklinikum Freiburg; 22.07.2015, Freiburg.

13. Blümle A: Studienplanung unter Berücksichtigung der bereits vorhandenen

Evidenz; 22.07.2015, Universitätsklinikum Freiburg, Hautklinik, Freiburg.

14. Blümle A: Studienplanung unter Berücksichtigung der bereits vorhandenen Evidenz; 07.07.2015, Universitätsklinikum Freiburg, Herz- und Gefäßchirurgie,

Freiburg.

15. Blümle A: Studienplanung unter Berücksichtigung der bereits vorhandenen Evidenz; 14.04.2015, Universitätsklinikum Freiburg, Urologie, Freiburg.

16. Blümle A: Studienplanung unter Berücksichtigung der bereits vorhandenen

Evidenz; 02.03.2015, Universitätsklinikum Freiburg, Allgemein- und Viszeralchirurgie, Freiburg.

17. Meerpohl, J.J. Klinische Studien, Meta-Analysen und Systematische Reviews.

in Querschnittsbereich 1, Themenblock Intervention. 2015. 26.10.2015;

Freiburg, Germany. 18. Schmucker C: Disseminations Bias und Leitlinien – was ist erforderlich im

Hinblick auf unpublizierte Daten? Leitlinienseminar der AWMF 2015;

06.11.2015, Berlin. 19. Voigt-Radloff S: Evidenzbasierte Innovationen in den Gesundheits-

fachberufen. Cochrane-GISKID-Seminar "Evidenzbasierte Innovationen in den

Gesundheitsfachberufen"; 22.-23.09.2015, Heidelberg. 20. Voigt-Radloff S: Von der Forschung zur evidenzbasierten Praxis - Autobahn

oder Baustelle? Seminar an der Hochschule Fulda; 20.01.2015, Fulda.